CTNNB1 and hepatocellular carcinoma: Also, specific gene mutations in HCC organoid models were associated with drug sensitivity or resistance: LGK974, which was one of the screened drugs, inhibited HCC organoids that presented Wnt pathway mutations, while it was ineffective in models carrying the catenin beta 1 (CTNNB1) mutation.